Wolfgang Miesbach: From genes to mechanisms – An Outstanding Update on Inherited Platelet Disorders
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“From genes to mechanisms.
An outstanding update on inherited platelet disorders (IPD) by Paolo Gresele and Loredana Bury at the EHA-SWG Scientific Meeting on Bleeding and Platelet Disorders in Florence.
Inherited platelet disorders were presented as heterogeneous group of bleeding disorders, encompassing both inherited thrombocytopenias (IPND) and inherited platelet function disorders (IPFD), driven by defects in megakaryocyte maturation, pro‑platelet formation, signalling pathways, granule biology, membrane receptors, transcription factors and the cytoskeleton.
The speakers offered a very practical clinical classification, distinguishing isolated thrombocytopenia, thrombocytopenia with additional congenital anomalies and predisposition syndromes, and highlighted syndromic forms with multi‑organ involvement as well as the broad spectrum of platelet function defects and their impact on bleeding.
Data from large cohorts, including surgical series, clearly show that patients with IPD have a significantly increased risk of peri‑procedural bleeding – especially in cardiovascular, urologic, gynecologic, ENT and plastic surgery – and that women are particularly affected by heavy menstrual and obstetric bleeding, with major consequences for quality of life.
Structured bleeding assessment, standardized platelet function testing and modern genetic diagnostics are essential to stratify bleeding risk, recognize syndromic forms early, guide peri‑operative management and enable informed genetic counselling – laying the groundwork for more individualized, mechanism‑based therapies in the future.”

Other posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series